BofA and UBS to lead Sandoz spin-off from Novartis
![A logo sign outside of a facility occupied by Novartis in Vienna, Austria, on September 5, 2018.](https://assets.euromoneydigital.com/dims4/default/514bbcd/2147483647/strip/true/crop/4000x2667+0+0/resize/840x560!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Fb8%2F69%2Facc0094c4c138f9ad6e7529adc78%2Fpp6426.jpg)
The Swiss medical company said it opted for a direct listing for tax purposes
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: